Condition
Thrombotic Stroke
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05417009Not ApplicableCompleted
Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke.
NCT03897478Unknown
Biomarkers of Acute Stroke in Clinic
NCT02014896Completed
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
NCT02344901CompletedPrimary
ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)
NCT01637129Phase 1Completed
Transcranial Magnetic Stimulation in Children With Stroke
Showing all 5 trials